S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

NAVB Navidea Biopharmaceuticals Inc (CE)

0.001

0.00 (0.00%)

Last Updated: 10:00:00

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Navidea Biopharmaceuticals (CE) (USOTC:NAVB)
Historical Stock Chart
From Aug 2024 to Oct 2024

Click Here for more Navidea Biopharmaceuticals (CE) Charts.

Navidea Biopharmaceuticals (CE) (USOTC:NAVB)
Historical Stock Chart
From Oct 2023 to Oct 2024

Click Here for more Navidea Biopharmaceuticals (CE) Charts.

Navidea Biopharmaceuticals Inc (PK) News

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Tuesday 6 February 2024 (8 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Thursday 1 February 2024 (8 months ago) • Edgar (US Regulatory)

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Saturday 27 January 2024 (8 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Saturday 27 January 2024 (8 months ago) • Edgar (US Regulatory)

Form POS AM - Post-Effective amendments for registration statement
Saturday 27 January 2024 (8 months ago) • Edgar (US Regulatory)

Form 15-12G - Securities registration termination [Section 12(g)]
Saturday 27 January 2024 (8 months ago) • Edgar (US Regulatory)

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Wednesday 17 January 2024 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 21 November 2023 (10 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 21 November 2023 (10 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 14 November 2023 (11 months ago) • Edgar (US Regulatory)

More Navidea Biopharmaceuticals Inc (PK) News Articles

Australian SE All Ordina...

S&P ASX 300 Metals and M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions